| __timestamp | MorphoSys AG | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55962693 | 22223073 |
| Thursday, January 1, 2015 | 78655788 | 6966842 |
| Friday, January 1, 2016 | 95723069 | 9000499 |
| Sunday, January 1, 2017 | 116808575 | 13741186 |
| Monday, January 1, 2018 | 106397017 | 19040000 |
| Tuesday, January 1, 2019 | 108431600 | 23559000 |
| Wednesday, January 1, 2020 | 141426832 | 31931000 |
| Friday, January 1, 2021 | 225200000 | 44981000 |
| Saturday, January 1, 2022 | 297812160 | 54234000 |
| Sunday, January 1, 2023 | 283614139 | 63806000 |
Data in motion
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, MorphoSys AG and Viking Therapeutics, Inc. have demonstrated contrasting approaches to R&D spending. MorphoSys AG, a leader in the field, has consistently increased its R&D budget, peaking at approximately 298% growth from 2014 to 2022. In contrast, Viking Therapeutics, Inc. has shown a more conservative yet steady increase, with a notable 187% rise in the same period. This divergence highlights MorphoSys AG's aggressive pursuit of innovation, while Viking Therapeutics, Inc. adopts a more measured approach. As of 2023, MorphoSys AG's R&D expenditure is over four times that of Viking Therapeutics, Inc., underscoring its commitment to maintaining a competitive edge in the biotech sector. This strategic focus on R&D is pivotal for both companies as they navigate the challenges and opportunities in the ever-evolving biotech industry.
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Genmab A/S vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Blueprint Medicines Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Viking Therapeutics, Inc. and Galapagos NV